**Triple Negative Breast Cancer Market Projected to Grow at 4.7% CAGR Through 2034**
The market for triple negative breast cancer (TNBC) treatments is anticipated to expand at a compound annual growth rate (CAGR) of 4.7% by the year 2034, according to estimates from DelveInsight. This growth is driven by ongoing research, development of new therapies, and increasing awareness of this aggressive breast cancer …